Abstract: Provided herein are methods of treating a variety of disorders related to fat accumulation in humans with pharmaceutical formulations containing deoxycholic acid.

Abstract: Provided herein are methods of treating a variety of disorders related to fat accumulation in humans with pharmaceutical formulations containing deoxycholic acid.

Abstract: An earth station interface architecture provides full mesh connectivity for a relatively small number of network stations. A component of the architecture is a switch, which employs' a network interface standard to ‘define the multiplexing of multiple virtual ports across single physical communications port. Through address and control fields of its connectivity control software, the switch can be dynamically configured to provide multilayer addressing, and device selectivity, thereby enabling point-to-point connectivity of multiple terminal devices, such as a plurality of audio circuits, to be effected via a single port. Dial codes on the station side of an audio signal multiplexer link are translated into frame relay addresses (data link connection identifiers) that are added to each frame of data for routing through the network. With this additional layer of routing information, audio (voice) connectivity is now available between any two audio circuits (e.g. trunks) in the network.

Abstract: Embodiments of the invention are directed to a method of estimating the physical stability of a protein formulation. A particular embodiment of the invention places the protein formulation under an agitational stress that causes the protein to aggregate at an accelerated rate. In one embodiment, the change in protein aggregation is monitored spectroscopically using Thioflavin-T. Embodiments of the invention then utilize a survival curve analysis to ascertain the relative physical stability of the different protein formulations under study. This method was used to develop novel surfactant-stabilized insulin formulations in a rapid, cost efficient manner, thus illustrating the utility of the inventive method to the discovery and development of pharmaceutical protein formulations.

Abstract: A satellite transceiver card for use in a communication system is provided. The satellite transceiver card can selectively adjusting bandwidth allocation or provide voice across a satellite communication system supporting Internet related applications. The satellite transceiver card may simply be a TDMA or single carrier per channel based transceiver, and can adapt to different rates and/or frequencies. The satellite transceiver card may include one or more high speed receiver(s) receiving one or more high speed downlink channels. The satellite transceiver card may also include one or more uplink transmitter(s). The uplink transmitter may be a single carrier per channel, a TDMA based system, or an adaptive system allowing dynamic reconfiguration of the uplink channel bandwidth and/or frequency. The transmitter may adapt to anyone of a number of different frequencies and/or channels.